Applications of cerebral SPECT

Clinical Radiology

Volumn 66, Issue 7, 2011, Pages 651-661

  McArthur, C ^a   Jampana, R ^a   Patterson, J ^a   Hadley, D ^a  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; DOPAMINE TRANSPORTER; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; L,L ETHYL CYSTEINATE DIMER; PENTETATE INDIUM IN 111; RADIOPHARMACEUTICAL AGENT; TETROFOSMIN TC 99M; THALLIUM CHLORIDE TL 201; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APHASIA; ARTERY EMBOLISM; ATHEROSCLEROSIS; AUTOPSY; BASAL GANGLION; BEHAVIOR CHANGE; BLOOD BRAIN BARRIER; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN TUMOR; CANCER RECURRENCE; CAROTID ARTERY OBSTRUCTION; CELL METABOLISM; CEREBELLUM; CEREBROSPINAL FLUID; CLINICAL EFFECTIVENESS; COMPLEX PARTIAL SEIZURE; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DEMENTIA; DIAGNOSTIC VALUE; DIFFUSE LEWY BODY DISEASE; DISEASE COURSE; DRUG DISTRIBUTION; ELECTROENCEPHALOGRAM; EPILEPTIC FOCUS; FRONTAL LOBE; HERPES SIMPLEX ENCEPHALITIS; HIGH RISK PATIENT; HIPPOCAMPAL SCLEROSIS; HUMAN; INTERMETHOD COMPARISON; LIQUORRHEA; MIDDLE CEREBRAL ARTERY; MOTOR CORTEX; MULTIINFARCT DEMENTIA; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PATHOLOGY; PERSONALITY DISORDER; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SENSORY CORTEX; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEREOISOMERISM; SUBCORTEX; TEMPORAL LOBE; THALAMUS; TRANSIENT ISCHEMIC ATTACK; VISUAL HALLUCINATION;

BLOOD-BRAIN BARRIER; BRAIN; HUMANS; MENTAL DISORDERS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79957705201     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2010.12.015     Document Type: Review

References (35)

1. Assessment of brain SPECT. Report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology 1996;46:278-85.
2. Health NCCfM. A NICE-SCIE guideline on supporting people with dementia and their carers in health and social care. National Clinical Practice Guideline Number 42. London: The British psychological society and the Royal College of Psychiatrists; 2007.
3. Conditions TNCCfC. Parkinson's disease: national clinical guideline for diagnosis and management in primary and secondary care. London: RoyalCollege of Physicians; 2006.
4. Cancer TNCCf. Improving outcomes for people with brain and other CNS tumours. London: National Institute for Health and Clinical Excellence; 2006.
5. Masdeu JC, Arbizu J. Brain single photon emission computed tomography: technological aspects and clinical applications. Semin Neurol 2008;28:423-34.
6. Catafau AM. Brain SPECT in clinical practice. Part I: perfusion. J Nucl Med 2001;42:259-71. (Pubitemid 32150517)
7. Sharp PF, Smith FW, Gemmell HG, et al. Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med 1986;27:171-7. (Pubitemid 17024858)
8. 99mTc-HMPAO injection to SPECT data acquisition: healthy subjects and patients with rCBF pattern. Eur J Nucl Med Mol Imaging 2008;35:2212-9.
9. Camargo EE. Brain SPECT in neurology and psychiatry. J Nucl Med 2001;42:611-23. (Pubitemid 32298283)
10. Warwick JM. Imaging of brain function using SPECT. Metab Brain Dis 2004;19:113-23. (Pubitemid 39005630)
11. Reisberg B, Burns A, Brodaty H, et al. Diagnosis of Alzheimer's disease. Report of an international psychogeriatric association special meeting work group under the cosponsorship of Alzheimer's disease international, the European Federation of Neurological Societies, the World Health Organization, and the World Psychiatric Association. Int Psychogeriatr 1997;9(Suppl. 1):11-38. (Pubitemid 28045337)
12. Lobotesis K, Fenwick JD, Phipps A, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001;56:643-9. (Pubitemid 32209999)
13. 99mTc-HMPAO-SPECT in dementia. Am J Geriatr Psychiatry 2004;12:554-70.
14. Jagust W, Thisted R, Devous Sr MD, et al. SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study. Neurology 2001;56:950-6. (Pubitemid 32290814)
15. 99mTc-HMPAO SPECT cerebral perfusion measurements during the first 48 hours for the localization of cerebral infarction. Stroke 1997;28:976-80.
16. Giubilei F, Lenzi GL, Di Piero V, et al. Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke. Stroke 1990;21:895-900. (Pubitemid 20209716)
17. Mahagne MH, Darcourt J, Migneco O, et al. Early (99m)Tc-ethylcysteinate dimer brain SPECT patterns in the acute phase of stroke as predictors of neurological recovery. Cerebrovasc Dis 2000;10:364-73.
18. Berrouschot J, Barthel H, Hesse S, et al. Differentiation between transient ischemic attack and ischemic stroke within the first six hours after onset of symptoms by using 99mTc-ECD-SPECT. J Cereb Blood Flow Metab 1998;18:921-9. (Pubitemid 28359911)
19. Cikrit DF, Dalsing MC, Harting PS, et al. Cerebral vascular reactivity assessed with acetazolamide single photon emission computer tomography scans before and after carotid endarterectomy. Am J Surg 1997;174:193-7. (Pubitemid 27383287)
20. Devous Sr MD, Thisted RA, Morgan GF, et al. SPECT brain imaging in epilepsy: a meta-analysis. J Nucl Med 1998;39:285-93. (Pubitemid 28114519)
21. de Silva R, Duncan R, Patterson J, et al. Regional cerebral perfusion and amytal distribution during the Wada test. J Nucl Med 1999;40:747-52. (Pubitemid 29210747)
22. Cilia R, Marotta G, Benti R, et al. Brain SPECT imaging in multiple system atrophy. J Neural Transm 2005;112:1635-45. (Pubitemid 41598969)
23. Catafau AM. Brain SPECT of dopaminergic neurotransmission: a new tool with proved clinical impact. Nucl Med Commun 2001;22:1059-60. (Pubitemid 33015969)
24. 123I]-FP-CIT study group. Mov Disord 2000;15:503-10.
25. Hierholzer J, Cordes M, Venz S, et al. Loss of dopamine-D2 receptor binding sites in parkinsonian plus syndromes. J Nucl Med 1998;39:954-60. (Pubitemid 28270107)
26. Cruickshank GS. Chapter 6, The use of SPECT in the analysis of brain tumours. In: Duncan R, editor. SPECT imaging of the brain. Glasgow: Kluwer Academic; 1997. pp. 161-78.
27. Martinez del Valle MD, Gomez-Rio M, Horcajadas A, et al. False positive thallium-201 SPECT imaging in brain abscess. Br J Radiol 2000;73:160-4. (Pubitemid 30179224)
28. Oriuchi N, Tamura M, Shibazaki T, et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 1993;34:2085-9. (Pubitemid 24002947)
29. Yoshii Y, Satou M, Yamamoto T, et al. The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumours in man and their response to treatment. Eur J Nucl Med 1993;20:39-45. (Pubitemid 23015335)
30. Kita T, Hayashi K, Yamamoto M, et al. Does supplementation of contrast MR imaging with thallium-201 brain SPECT improve differentiation between benign and malignant ring-like contrast-enhanced cerebral lesions? Ann Nucl Med 2007;21:251-6.
31. Kuwert T, Woesler B, Morgenroth C, et al. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine. J Nucl Med 1998;39:23-7. (Pubitemid 28063167)
32. Filippi L, Schillaci O, Santoni R, et al. Usefulness of SPECT/CT with a hybrid camera for the functional anatomical mapping of primary brain tumors by [Tc99m] tetrofosmin. Cancer Biother Radiopharm 2006;21:41-8.
33. 99mTc-tetrofosmin SPECT/CT with a hybrid camera. Cancer Biother Radiopharm 2009;24:229-35.
34. Novotny C, Potzi C, Asenbaum S, et al. SPECT/CT fusion imaging in radionuclide cisternography for localization of liquor leakage sites. J Neuroimaging 2009;19:227-34.
35. Schillaci O, Danieli R, Manni C, et al. Is SPECT/CT with a hybrid camera useful to improve scintigraphic imaging interpretation? Nucl Med Commun 2004;25:705-10.